Joanne Jenkins Lager - Jun 24, 2021 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Medical Officer
Signature
/s/ Michel Detheux, as Attorney-in-Fact
Stock symbol
ITOS
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 08:00 PM
Next filing
Nov 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest over 4 years, with 25% vesting on June 24, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.